Add BrightSurf on Google Email

Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study published in Clinical Infectious Diseases

A global Phase 2/3 clinical trial found that vaccination with SCB-2019 reduced the risk of transmitting SARS-CoV-2 infection to household members. The study showed a significant reduction in symptomatic cases among vaccinated household contacts and indicated that vaccines can play an important role in controlling future outbreaks.

SourceInternational Vaccine Institute·JournalClinical Infectious Diseases·TypeRandomized controlled/clinical trial·DateNov 30, 2022

Chinese Medical Journal study explores the association of influenza vaccination with COVID-19 infection and associated outcomes

A systematic review of 36 studies found that influenza vaccination reduced the risk of SARS-CoV-2 infection by 20% and poor outcomes like ICU admission and death by 17-31%. The findings suggest that routine influenza vaccination could offer non-specific immunity against COVID-19 symptoms.

SourceCactus Communications·JournalChinese Medical Journal·TypeMeta-analysis·DateNov 22, 2022

The allocation of COVID-19 vaccinations in 29 countries at the beginning of 2021

Researchers mapped out variations in vaccine distribution policies among 29 countries, highlighting differing priorities such as age, comorbidities, and occupation. The study suggests that vaccination schedules differ from resource allocation strategies in healthcare, reflecting diverse moral judgments underlying each approach.

SourceInterdisciplinary Centre for Ethics, Jagiellonian University in Kraków·JournalJournal of Law and the Biosciences·TypeContent analysis·DateNov 9, 2022

SARS-CoV-2 placentitis, and how maternal COVID-19 vaccination could prevent stillbirth

A recent literature review found that vaccination against SARS-CoV-2 can effectively prevent adverse conditions such as stillbirth and infant death. Pregnant women with COVID-19 have an increased risk for stillbirth compared to uninfected women, and those who vaccinate can more effectively prevent these events.

SourceMassachusetts General Hospital·JournalAJOG Global Reports·TypeLiterature review·DateOct 21, 2022

Variation in HPV vaccination effectiveness by age at vaccination

A recent study published in JAMA Network Open found that human papillomavirus (HPV) vaccination effectiveness differs significantly depending on the age at which it is administered. The researchers analyzed self-reported data from female participants and discovered that HPV vaccination is most effective when administered earlier in life.

SourceJAMA Network·JournalJAMA Network Open·DateOct 21, 2022

Monkeypox: High vaccine acceptance among users of European gay-dating apps

A survey among European gay-dating app users found a 82% crude vaccination acceptance rate. Willingness to vaccinate increased with factors like perceived severity of monkeypox, transmission risk, and existing health links. Higher acceptance rates were seen in northern and western Europe compared to southern and eastern regions.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeSurvey·DateOct 20, 2022

Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines, according to JNCCN study

Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateOct 17, 2022

Fourteen per cent decrease in live births in Europe nine months after the start of the COVID-19 pandemic and first lockdowns

A 14% decrease in live births was observed in Europe nine months after the start of the COVID-19 pandemic and first lockdowns. The decline may be linked to lockdowns rather than COVID-19 infection, with countries experiencing longer lockdowns having lower birth rates.

SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction·TypeObservational study·DateOct 13, 2022

How does social behavior lead to clusters of vaccine hesitancy?

Researchers created theoretical models to explain geographical clustering of vaccine hesitancy, attributing it to both social selection and social influence. The models found that these two processes independently generate clusters of high hesitancy, with social selection playing a key role when societies trust propaganda.

SourcePLOS·JournalPLOS Computational Biology·TypeComputational simulation/modeling·DateOct 13, 2022

Research shows how poliovirus takes over cells from within

Poliovirus researchers at Umeå University have gained a new understanding of how the virus behaves in infected cells, revealing key protein roles and cellular processes involved. This breakthrough could lead to the development of new antiviral treatments and vaccines targeting the autophagy system.

SourceUmea University·JournalNature Communications·TypeNews article·DateOct 12, 2022

Neurologic complications of smallpox, monkeypox

This review examines the known neurologic complications of smallpox and monkeypox, including their complications from vaccination. The study highlights the importance of understanding these neurological effects to improve treatment and prevention strategies.

SourceJAMA Network·JournalJAMA Neurology·DateSep 20, 2022

HPV vaccinations before, during pandemic

Researchers found that HPV vaccination rates rose significantly during the pandemic, particularly among younger children and adolescents. The study suggests that the increased vaccination rates may be attributed to changes in healthcare access and scheduling.

SourceJAMA Network·JournalJAMA Network Open·DateSep 19, 2022

Moral values explain differences in COVID-19 vaccination rates across US counties

A study from USC Dornsife reveals that moral values, including care, fairness, loyalty, authority, and purity, predict regional differences in COVID-19 vaccination rates. Counties with residents prioritizing purity were less likely to be vaccinated, while those emphasizing loyalty and fairness had higher vaccination rates.

SourceUniversity of Southern California·JournalAmerican Psychologist·TypeData/statistical analysis·DateSep 15, 2022

The Lancet: New report details “massive global failures” of COVID-19 response, calls for improved multilateral cooperation to end pandemic and effectively manage future global health threats

The Lancet Commission report highlights widespread, global failures in the COVID-19 response, resulting in millions of preventable deaths and reversed progress towards UN SDGs. The report calls for strengthened multilateral cooperation, improved technology, and international health financing to address future health threats.

SourceThe Lancet·JournalThe Lancet·TypeSystematic review·DateSep 14, 2022

Study: Minority, immigrant populations faced misinformation, hostility when seeking COVID-19 information online

A new study from the University of Kansas found that racial and ethnic minority populations in the US faced unique challenges while seeking COVID-19 information online, including misinformation, harassment, and hostility. Younger and healthier individuals were more resistant to vaccination due to lower perceived risk and benefit.

SourceUniversity of Kansas·JournalConvergence The International Journal of Research into New Media Technologies·TypeSurvey·DateSep 8, 2022

Rutgers study indicates who faces highest risk of HPV infection and anal cancer

A Rutgers study found that previous sexually transmitted infections and multiple sexual partners increase the risk of new HPV infections in men who have sex with men, other cisgender sexual minority men, and transgender women. The study also highlights the importance of HPV vaccination and regular screening to prevent anal cancer.

SourceRutgers University·JournalAmerican Journal of Men s Health·TypeSurvey·DateSep 7, 2022

Those suffering from autoimmune diseases require a third coronavirus vaccination

A study published in The Lancet Rheumatology found that booster vaccinations significantly increase immune protection for individuals with autoimmune diseases such as rheumatism and inflammatory bowel disease. Most patients experienced no significant side effects after receiving a third vaccination, and their antibodies effectively pro...

SourceFriedrich-Alexander-Universität Erlangen-Nürnberg·JournalThe Lancet Rheumatology·DateSep 2, 2022